Nurul Atiah Mohd Ali1,2, Ahmad Fazlin Nasaruddin2, Syarah Syamimi Mohamed1, Wan Faiziah Wan Rahman1,3. 1. Department of Pathology, School of Medical Sciences, Universiti Sains Malaysia, Health Campus, 16150, Kubang Kerian, Kelantan, Malaysia. 2. Department of Pathology, Hospital Sultanah Nur Zahirah, 20400, Kuala Terengganu, Terengganu, Malaysia. 3. Hospital Universiti Sains Malaysia, 16150, Kubang Kerian, Kelantan, Malaysia.
Abstract
OBJECTIVE: Phyllodes tumour (PT) is a rare fibroepithelial neoplasm of the breast that carries a risk of malignancy. Histopathological examination remains a gold standard for diagnosis. The usage of the immunohistochemical markers of Ki67 and p53 acts as a supplement method, particularly for the malignant PT. We aim here to study the expression of these markers in PT and to see their relation to the tumour grading. METHODOLOGY: We conducted a retrospective cross-sectional study on 57 archived formalin-fixed paraffin-embedded tissue blocks of PT from the years 2015 to 2018 from two hospitals in East Coast Malaysia. The histopathological examination and immunohistochemical stain for Ki67 and p53 were analysed. RESULTS: There was an association between clinical descriptive data of skin changes, lump size of more than 3 cm, cytological atypia, stromal hypercellularity, mitosis and immunohistochemistry with the clinical diagnosis of PT. Both marked expression of Ki67 and p53 were seen in borderline and malignant PT. Our study showed that in the presence of high mitotic figures, marked expression of Ki67 was only seen in cases of malignant PT. CONCLUSION: We found a significant association of Ki67 and p53 expressions, high mitosis and other descriptive histopathological features in malignant PT. Further study with larger sample size is recommended to predict tumour grade and prognosis as well as the disease-free survival of the tumour. <br />.
OBJECTIVE:Phyllodestumour (PT) is a rare fibroepithelial neoplasm of the breast that carries a risk of malignancy. Histopathological examination remains a gold standard for diagnosis. The usage of the immunohistochemical markers of Ki67 and p53 acts as a supplement method, particularly for the malignant PT. We aim here to study the expression of these markers in PT and to see their relation to the tumour grading. METHODOLOGY: We conducted a retrospective cross-sectional study on 57 archived formalin-fixed paraffin-embedded tissue blocks of PT from the years 2015 to 2018 from two hospitals in East Coast Malaysia. The histopathological examination and immunohistochemical stain for Ki67 and p53 were analysed. RESULTS: There was an association between clinical descriptive data of skin changes, lump size of more than 3 cm, cytological atypia, stromal hypercellularity, mitosis and immunohistochemistry with the clinical diagnosis of PT. Both marked expression of Ki67 and p53 were seen in borderline and malignant PT. Our study showed that in the presence of high mitotic figures, marked expression of Ki67 was only seen in cases of malignant PT. CONCLUSION: We found a significant association of Ki67 and p53 expressions, high mitosis and other descriptive histopathological features in malignant PT. Further study with larger sample size is recommended to predict tumour grade and prognosis as well as the disease-free survival of the tumour. <br />.
Authors: Veselina B Korcheva; Judith Levine; Carol Beadling; Andrea Warrick; Gayle Countryman; Neal R Olson; Michael C Heinrich; Christopher L Corless; Megan L Troxell Journal: Appl Immunohistochem Mol Morphol Date: 2011-03
Authors: Alex K H Tsang; Siu Ki Chan; Christopher C F Lam; Philip C W Lui; Helen H L Chau; Puay Hoon Tan; Gary M Tse Journal: Histopathology Date: 2011-09-14 Impact factor: 5.087
Authors: Melinda L Telli; Kathleen C Horst; Alice E Guardino; Frederick M Dirbas; Robert W Carlson Journal: J Natl Compr Canc Netw Date: 2007-03 Impact factor: 11.908
Authors: Yvonne Noronha; Anwar Raza; Brian Hutchins; Donald Chase; Carlos Garberoglio; Peiguo Chu; Lawrence Weiss; Jun Wang Journal: Int J Surg Pathol Date: 2010-11-17 Impact factor: 1.271
Authors: Germana Lissidini; Antonino Mulè; Angela Santoro; Giovanni Papa; Luca Nicosia; Enrico Cassano; Arwa Ahmed Ashoor; Paolo Veronesi; Liron Pantanowitz; Jason L Hornick; Esther Diana Rossi Journal: Pathologica Date: 2022-04-13
Authors: Juergen Hench; Tatjana Vlajnic; Savas Deniz Soysal; Ellen C Obermann; Stephan Frank; Simone Muenst Journal: Cancers (Basel) Date: 2022-01-28 Impact factor: 6.639